Advertisement
KMB vs KVUE
Which Stock Would AI Choose? Kimberly-Clark (KMB) vs. Kenvue (KVUE) Stock Comparison
Key Takeaways
- Both KMB and KVUE have shown positive year-to-date gains of around 10-12% amid recent market activity, driven by anticipation of their $48.7 billion merger set to close in the second half of 2026.
- KMB, a leader in personal care and tissue products, trades at approximately $111 with a 4.59% dividend yield, reflecting stability in consumer staples.
- KVUE, focused on consumer health brands like Tylenol and Neutrogena, trades near $19 and recently beat Q4 earnings estimates, boosting short-term momentum.
- The pending acquisition highlights synergies with potential $2.4 billion in annual cost savings, reshaping both companies' growth profiles in personal care and health.
- Relative performance shows KVUE gaining from earnings strength, while KMB offers higher profitability with a P/E of 22.93 versus KVUE's 25.16.
- Investors weigh merger execution risks against combined scale in a $240 billion addressable market for daily essentials.
Introduction
This stock comparison examines KMB (Kimberly-Clark Corporation) and KVUE (Kenvue Inc.), two leaders in consumer staples and health products whose paths have converged through a transformative $48.7 billion acquisition agreement. Both companies serve essential daily needs with powerhouse brands, but recent market activity, earnings results, and merger developments have shaped their relative performance. Traders seeking short-term momentum and investors focused on dividend stability or merger arbitrage will find value in analyzing their business models, recent trends, and positioning. This analysis draws on verifiable data to highlight contrasts in growth drivers, risks, and sentiment in the current environment.
KMB Overview and Recent Performance
Kimberly-Clark Corporation (KMB) is a global leader in personal care, consumer tissue, and professional products, operating through segments like North America Personal Care and International Family Care & Professional. Iconic brands such as Huggies, Kleenex, Scott, Kotex, and Depend generate over 80% of its $16.45 billion trailing twelve-month revenue, serving markets in more than 175 countries.
In recent weeks, KMB shares have risen about 10% year-to-date and 2.45% over the past week, trading around $111 with a market cap of $37 billion. This momentum stems from shareholder approval of the Kenvue acquisition and presentations outlining "Powering Care" integration plans, projecting $2.4 billion in synergies. Sentiment reflects a balance of valuation discounts—trading at a 40% discount to future cash flows—and debt concerns, offset by robust 4.59% dividend yield and EPS of $4.86. Broader one-year declines of around 17% underscore caution amid integration risks, yet recent upticks signal growing optimism for combined scale.
KVUE Overview and Recent Performance
Kenvue Inc. (KVUE) stands as the world's largest pure-play consumer health company, with $15.12 billion in trailing revenue from segments including Self Care, Skin Health and Beauty, and Essential Health. Brands like Tylenol, Neutrogena, Listerine, BAND-AID, and Johnson's dominate over-the-counter medicines, skincare, and oral care, reaching over 1.2 billion consumers globally.
Recent market activity has propelled KVUE shares up roughly 10-12% year-to-date and 9% monthly, closing near $19 with a $36.6 billion market cap. Q4 2025 results exceeded estimates, with EPS of $0.27 versus $0.22 expected and net sales of $3.78 billion, alongside a 3.5% global workforce optimization amid merger progress. Trading below the deal's implied $18-21 value creates arbitrage interest, though litigation like Tylenol suits tempers enthusiasm. A 4.34% dividend yield supports income focus, with one-year returns lagging at about -17% due to standalone challenges now alleviated by the Kimberly-Clark tie-up.
Trending AI Robots
Tickeron's Trending AI Robots page showcases over 25 top-performing AI trading bots curated from hundreds available on the platform, which collectively trade thousands of tickers across stocks, ETFs, and crypto. AI rigorously analyzes all bots to spotlight those best suited to current market conditions, including volatility levels from low to high, highlighting promising strategies in sectors like semiconductors, aerospace, industrials, and consumer staples. Performance metrics stand out: annualized returns range from +14% to +246%, win rates 55-95%, and profit factors up to 25.83, with examples like SOXL ETF bots at +103-116% returns and multi-ticker strategies exceeding 70% gains. These bots vary in styles—signal, virtual, brokerage agents—timeframes (5-60 minutes), and risk management, enabling diversified approaches. Explore Tickeron's Trending AI Robots to identify tools aligned with today's stock comparison dynamics.
Head-to-Head Comparison
KMB and KVUE overlap in consumer essentials but diverge in focus: KMB's tissue and incontinence emphasis versus KVUE's OTC drugs and skincare. Growth drivers for KMB include "Powering Care" innovation and 12 powerhouse brands in a $240 billion market, while KVUE leverages 10 billion-dollar brands amid margin gains from pricing.
Recent momentum favors KVUE post-earnings, yet KMB shows trend consistency with higher ROIC. Risks for KMB center on acquisition debt and dividend sustainability; KVUE faces litigation and volume softness. Both in consumer staples, sentiment tilts toward merger upside, trading KMB at a relative discount despite superior EPS ($4.86 vs. $0.76).
Tickeron AI Verdict
Tickeron's AI currently leans toward KMB based on observable factors like superior profitability, dividend reliability nearing 5%, and strategic positioning as the acquirer with projected synergies. While KVUE exhibits stronger near-term momentum from earnings beats, KMB's trend stability and lower relative valuation suggest higher probability of outperformance through merger integration, barring regulatory delays.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMB is a Hold and KVUE is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KMB’s FA Score shows that 2 FA rating(s) are green whileKVUE’s FA Score has 1 green FA rating(s).
- KMB’s FA Score: 2 green, 3 red.
- KVUE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KMB’s TA Score shows that 2 TA indicator(s) are bullish while KVUE’s TA Score has 3 bullish TA indicator(s).
- KMB’s TA Score: 2 bullish, 5 bearish.
- KVUE’s TA Score: 3 bullish, 6 bearish.
Price Growth
KMB (@Household/Personal Care) experienced а -2.44% price change this week, while KVUE (@Household/Personal Care) price change was -1.56% for the same time period.
The average weekly price growth across all stocks in the @Household/Personal Care industry was -3.22%. For the same industry, the average monthly price growth was -3.61%, and the average quarterly price growth was -8.91%.
Reported Earning Dates
KMB is expected to report earnings on Jul 28, 2026.
KVUE is expected to report earnings on Aug 12, 2026.
Industries' Descriptions
@Household/Personal Care (-3.22% weekly)Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
| KMB | KVUE | KMB / KVUE | |
| Capitalization | 31.8B | 32.9B | 97% |
| EBITDA | 3.21B | 3.21B | 100% |
| Gain YTD | -3.762 | 1.531 | -246% |
| P/E Ratio | 18.55 | 20.37 | 91% |
| Revenue | 16.6B | 15.3B | 108% |
| Total Cash | 542M | N/A | - |
| Total Debt | 7.08B | 8.67B | 82% |
KMB | ||
|---|---|---|
OUTLOOK RATING 1..100 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 11 | |
PRICE GROWTH RATING 1..100 | 62 | |
P/E GROWTH RATING 1..100 | 49 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| KMB | KVUE | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 3 days ago 52% | 3 days ago 55% |
| Momentum ODDS (%) | 3 days ago 49% | 3 days ago 60% |
| MACD ODDS (%) | 3 days ago 51% | 3 days ago 59% |
| TrendWeek ODDS (%) | 3 days ago 52% | 3 days ago 65% |
| TrendMonth ODDS (%) | 3 days ago 47% | 3 days ago 46% |
| Advances ODDS (%) | 11 days ago 42% | 11 days ago 54% |
| Declines ODDS (%) | 3 days ago 50% | 7 days ago 65% |
| BollingerBands ODDS (%) | N/A | 3 days ago 52% |
| Aroon ODDS (%) | 3 days ago 41% | 3 days ago 39% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ISTB | 48.13 | -0.11 | -0.23% |
| iShares Core 1-5 Year USD Bond ETF | |||
| UNX | 44.20 | -0.13 | -0.30% |
| Tradr 2X Long U Daily ETF | |||
| IBND | 31.24 | -0.19 | -0.60% |
| State Street® SPDR® Blmbg Intl CorpBdETF | |||
| MMLG | 35.98 | -0.51 | -1.41% |
| First Trust Multi-Manager Large Gr ETF | |||
| MTYY | 4.40 | -0.07 | -1.56% |
| GraniteShares YieldBoost MSTR ETF | |||
KVUE and
Correlation & Price change
A.I.dvisor indicates that over the last year, KVUE has been loosely correlated with KMB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KVUE jumps, then KMB could also see price increases.
| Ticker / NAME | Correlation To KVUE | 1D Price Change % | ||
|---|---|---|---|---|
| KVUE | 100% | -0.47% | ||
| KMB - KVUE | 39% Loosely correlated | -0.79% | ||
| CL - KVUE | 30% Poorly correlated | -0.80% | ||
| UL - KVUE | 30% Poorly correlated | -0.98% | ||
| PG - KVUE | 28% Poorly correlated | -0.80% | ||
| CHD - KVUE | 27% Poorly correlated | -0.31% | ||
More | ||||